677
HLAVNÍ506722001005185134178232252
TÉMA533422001003981147194
Přínosy31703300100406581119158187224
a3410330010034
rizika3460330010024407187121157
nových363333001003675111150180217
antidiabetik38663300100347299115153168203241277303320354
pro423633001003761100
léčbu43523300100155081120158
geriatrických45263300100377297113147174199215245279318348385
pacientů492733001003873103119154191218257
s5200330010028
diabetem52443300100385387126161188223283
|5584220010018
437564222001004174106
/35838040010732
Vnitř3660804001074592111139166
Lék.3845804001074184122140
2024;70(7):430-4374005804001074487128168182224265290333358372416457500530577618658
/47088040010732
VNITŘNÍ48058040010746106127172221280301
LÉKAŘSTVÍ5128804001074084130188235279325377399
www.casopisvnitrnilekarstvi.cz42580400107651332012142542953293774274464795215705896176436927117307748128548809159449871007102310631101
27.425550085367180
Bilal52055008335516698113
A,6485500834155
Yi7185500833652
F,7855500833238
Gonzalez8385500834482121150184199234263
GR,1116550083448094
et12255500833456
al.1296550083324860
Effects1371550083335271105138162190
of15765500833756
newer16475500833873124158180
anti-hyperglycemic1842550083316991106128167198238274295333348380412445503518550
agents24075500833271106144166193
on26155500833776
cardiovascular2706550083316485123138176425650083326591123161176209230
outcomes668650083377597128165223258285
in9666500831553
older1032650083375392127148
adults:11936500833271108123146173186
Systematic1392650083326289112146204236258273305
review1710650083215587103138189
and19126500833169108
meta-analysis.20336500835893115148170203241273288320347362388401
J244765008325
Diabetes2485650083456092132167189223250
Complications.27486500834077135425750083395570101134156171209248274288
20247287500833468101133
Aug;38(8):108783.8767500834178117129164199218251270281311343378411445479491
28.425850085367288
Ledesma5288500833166105140167224257
G,7998500834458
Umpierrez87185008344102141156191212234268298
GE,1183850083447791
Morley12888500835593115130165197
JE,1500850083245770
et15858500833456
al.1656850083324760
Efficacy173185008332506886118151183216
and19628500833270109
safety2085850083276079113135169
of22698500833756
linagliptin2340850083153068100139154169208231246284
to26388500832259
improve271285008314721111331704259500833266
glucose506950083385491123160187222
control7439500833268107128150187203
in9619500831553
older1029950083385492127149
people11939500833974113152168203
with1412950083506688126
type1554950083215595131
2170095008334
diabetes1750950083385385124160182216242
on20089500833776
stable2099950083264982121137172
insulin2286950083155379116132147185
therapy:2486950083226095116149188220233
A273495008341
randomized279195008320539142510500833876135150179213252
trial.693105008321435890106119
Diabetes8271050083456193132168190224250
Obes109310500834787122149
Metab.125710500835590112145184197
2019146910500833468100130
Nov;21(11):2465-2473.161510500834483115128163194209241268283295330362398432454485517549583595
29.4251150085367285
Doucet52511500834584122154188210
J,74911500832436
Chacra79911500834078110142164197
A,101011500834155
Maheux107911500835487125160197229
P,132211500833539
et137511500833457
al.14451150083324861
Efficacy1520115008332506886118151183216
and175011500833270109
safety18731150083265978113135169
of205611500833756
saxagliptin21261150083265991124163178193232254269307
in244711500831553
older25141150083375392127148
patients26761150083387193108143181203230
with4251250083516689127
type5671250083225595131
2713125008334
diabetes7631250083385385124160182216243
mellitus.102112500835792108123138160198225238
Curr12751250083407697119
Med140912500835590129
Res15541250083357097
Opin.166612500834787103140154
2011183512500833468100128
Apr;27(4):863-9.197812500834180102115150183200233250262297332366388423434
30.4251350085367287
Karyekar5291350083356890124158188222243
CS,7881350083407487
Ravichandran8911350083356899115147185217255294316349387
S,129413500833245
Allen13551350083415672106144
E,151613500833245
et157713500833457
al.16501350083314760
Tolerability17261350083326682117138171211226241256279313
and205513500833169108
efficacy2180135008333527088120153185218
of241413500833757
glycemic24871350083385385117150208223255
control2758135008332681071284251450083215874
with5131450083516689127
saxagliptin6541450083265991124163178193232254269307
in97614500831452
older10421450083385492127149
patients12051450083397193109143181203231
(aged14501450083184988123162
≥1627145008341
65168314500833468
years)17651450083316597118145162
with19421450083506688126
inadequately20831450083145285124159198236268290323339371
controlled246814500833168107128150187203218253292
type27751450083215595130
2425155008334
diabetes4741550083395486125160183217243
mellitus.73315500835792108123138160198224238
Clin9861550083405570108
Interv11101550083145274108129164
Aging.12891550083417994132171184
2013;8:419-30.148915500833468100130141176189223253283307339374387
31.4251650085366879
Iqbal5151650083155290122136
N,66316500834456
Allen7301650083405569103139
E,88116500833244
Öhman93616500834784140172208
P.115616500833439
Long-term120616500833167104142163184217237294
safety15111650083265876109130163
and168516500833268106
tolerability18021650083225772106126158196210224238260292
of210516500833756
saxagliptin21721650083255788119157171185223244258295
add-on247816500833270107129167204
therapy26931650083225992113144182212
in42517500831450
older4861750083375188121141
patients6381750083376989103136172192218
(aged8671750083184784117155
≥1032175008341
65108417500833466
years)11601750083306393113138154
with13251750083496384121
type14561750083225492125
21592175008333
diabetes.16361750083375181119153173205231243
Clin18891750083405367103
Interv20031750083145070102122155
Aging.21691750083407690126163175
201423551750083336596125
Sep249017500833266103
4;9:1479-87.2604175008333447789117147177209231265296301
32.4251850085367186
Pratley5291850083355689111126161192
RE,7381850083366982
Rosenstock83718500833574100135174200223260293323
J,117718500832436
Pi-Sunyer12301850083354971103140178209243264
FX,15111850083327285
Banerji161318500833568106141162178193
MA,182318500835496111
Schweizer195018500833365103154188203232266288
A,225418500834155
Couturier232618500834077115138176197213247268
A,261118500834155
Dejager26831850083458196128167202223
S.42519500833246
Management48619500835487125157196231289324362384
of88519500833756
type9561950083225695131
21102195008334
diabetes11511950083385486125160183216243
in140919500831553
treatment-naive14771950083214377109131189224262283303342374389422456
elderly19481950083345089123145161192
patients:21551950083397294109144182203231244
benefits241419500833874112147164181204231
and266119500833169108
risks2784195008321376393122
of42520500833757
vildagliptin4972050083324762101134173188203242264279317
monotherapy.83020500835795134172194232267288321361392402
Diabetes12472050083456193132168190224251
Care.15132050083407394128140
2007166820500833569105137
Dec;30(12):3017-22.182120500834580113126161196215247277295307342376408438456487522534
33.4252150085367186
Round52821500833574112150189
EM,73321500833388101
Engel85121500833370109144160
SS,10272150083336578
Golm11212150083448399156
GT,12942150083437887
et139721500833456
al.14702150083314760
Safety15462150083336685119141175
of173721500833857
sitagliptin1810215008327416497136151166205227242280
in210721500831452
elderly21762150083344988123144160192
patients23842150083397294109144182203231
with26322150083506688126
type27752150083215595131
2425225008334
diabetes:4742250083395486125160183217243256
a745225008332
pooled79222500833978116132167207
analysis101422500833270102118149176191217
of124722500833756
25131922500833469
clinical1403225008331466199114146179195
studies.16132250083264987126141176203216
Drugs184522500834567105144170
Aging.20312250083417994132171184
2014223022500833469100131
Mar;31(3):203-14.237722500835487108121156187202236253265300334367389420451464
34.4252350085367388
Barnett5312350083356889128163185210
AH,7582350083418598
Huisman8732350083448297123181213251
H,114123500834557
Jones121523500832563101136163
R,139523500833650
et146223500833456
al.15352350083324760
Linagliptin16122350083324785117156172186226248263301
for19302350083185677
patients20252350083387193108143181203230
aged227223500833271106146
70243523500833467
years25192350083316597118145
or268123500833859
older27572350083385492127149
with4252450083506587124
type5612450083215493128
2701245008334
diabetes7472450083375283121156178210237
inadequately9962450083145183121155193230261282315330361
controlled136924500833167105126146183198213247285
with16662450083506587124
common180224500833167124181218256
antidiabetes20702450083316889104142156187226260282315341
treatments:24232450083214275107128185219256277304316
a2751245008331
randomised,2794245008321539042525500833876135150176211250263
double-blind,70325500833877115154170205228268284299336376388
placebo-controlled11072550083385486118152191230254287324363384406443459474509548
trial.1670255008322445991107119
Lancet.180525500833165103135168191204
2013202425500833569100130
Oct217025500834779103
26;382(9902):1413-23.22892550083346880115149183200233268304337355366396427458488509540575588
35.4252650085367085
Rosenstock5232650083357399134172198221257290319
J,85526500832436
Wilson9042650083577287113151189
C,110626500833952
Fleck11712650083324681113143
P.132726500833540
Alogliptin13792650083415694133148163202223238276
versus16682650083316586113150176
glipizide18562650083385368107122151166205239
monotherapy210826500835795133171192230265286318357388
in250926500831452
elderly25742650083334987122143158190
type27762650083225595130
2425275008334
diabetes4742750083385385124160182216242
mellitus73127500835792108123138160198225
patients9702750083397294109143182203231
with12152750083516689127
mild13572750083577287126
hyperglycaemia:149827500833768108143164203218250281314349407422454466
a1979275008331
prospective,20252750083386097124163199231255271303337349
double-blind,238927500833876114153169204227267283298336375388
randomized,2791275008321549242528500833876135150179213252265
1-year7052850083355385119151172
study.8932850083264987126158168
Diabetes10762850083466193132168190224251
Obes134228500834787122149
Metab.150728500835489111144183196
2013171828500833469100130
Oct;15(10):906-14.186428500834779103117147177194226257276288323359394418449480492
36.4252950085367389
Nagao53129500834578117150189
M,73729500835569
Sasaki8222950083336694128158175
J,101429500832437
Sugihara106829500833270110126164197219253
H,133829500834457
et141229500833457
al.14862950083314761
STREAM156429500833267105139183239
Study18202950083325492132165
Investigators.20022950083145385120148171187227260282320342370385
Efficacy2403295008333516987120153186220
and264029500833271110
safety2767295008326608011542530500832256
of49930500833858
sitagliptin575305008326426598138154170210232248287
treatment8803050083224479111134193228267290
in118830500831553
older12603050083375393129151
adults142930500833271110126149177
with16253050083506690128
moderately177230500835796137172194228250285301333
controlled212430500833169108130152190207222258298
type24413050083215696133
22592305008334
diabetes:26453050083385386126162185220247260
the4253150083226196
STREAM53831500833267105139183239
study.7943150083265089128161172
Sci9823150083336682
Rep.108031500833671111125
2023122131500833469103138
Jan13763150083245796
4;13(1):134.14883150083354778109127160175187218249285298
37.3047550085367079
Wang31435500835789127166
Y,33255500833543
Shao33845500833371103141
X,35415500833852
Liu3609550083314684
Z.37095500833851
Efficacy377655008332506886118151183217
and40095500833169108
safety4133550083276079113135169
of43185500833757
sodium-glucose43915500832664104119156214237277292330362399426461
co-transporter4868550083316891114135168206232271310332356390411
2529555008335
inhibitors53465500831452901051441603047650083225980107
in31696500831553
the3237650083226095
elderly3347650083344988123144160192
versus3554650083316687114151178
non-elderly37476500833776114136173188227262283299331
patients4093650083397293109143181203231
with4339650083506688126
type4480650083225696131
2462665008334
diabetes4675650083385486125160183216243
mellitus:49336500835893108123138161199225237
a518565008332
meta-analysis.52326500835893115148170202240273304775008315477488115128
Endocr31907500833371110148181202
J.34077500832537
202234597500833469101136
Jun36117500832461100
28;69(6):669-679.3726750083346880116150169202220232267303337361398431464475
38.3047850085367390
Pratley3154850083355690113129164197
R,33688500833650
Dagogo-Jack34368500834578118157197236260282315348378
S,38328500833346
Charbonnel38968500834078111133173213252291326343
B,42568500833649
et43238500833457
al.4397850083324862
Efficacy447685008333516987120154186221
and47148500833271110
safety4842850083266080115138172
of50328500833757
ertugliflozin5107850083345681120159175191209226265294310349
in54748500831453
older3047950083375392127149
patients3210950083387193109143182203231
with3455950083506689127
type3596950083215595131
2374195008334
diabetes:3789950083375385124160182216243256
A405995008341
pooled41149500833877116132167206
analysis43349500833270102118150177192219
of45679500833756
phase46379500833877109136171
III4822950083153046
studies.4882950083264987126142177204218
Diabetes5113950083456193133168191225252
Obes53799500834686122149
Metab.304710500835490113147187200
2020326410500833468102137
Dec;22(12):2276-2286341810500834581114128164199217250280299311347383416449473505540575611
39.30471150085367287
Bode315611500833675116152
B,333011500833549
Stenlöf34011150083335589129145184204
K,362711500833551
Sullivan37001150083337187103119153187226
D,394811500834557
et402711500833458
al.41071150083324862
Efficacy4191115008333516987120154187222
and443511500833271111
safety45681150083266180116139174
of476411500833758
canagliflozin484411500833165104137177194210228245284314330369
treatment52351150083224479112135194230269292
in304712500831553
older31201250083375494129151
subjects329112500832664104120156189214242
with35531250083516790129
type37021250083225697133
23855125008334
diabetes39091250083395487127163186221248
mellitus:417712500835893110125141164203230243
a4440125008332
randomized44921250083215493133172231246276311351
trial.4863125008322446093109123
Hosp500612500834483110150
Pract51761250083355690123148
(1995).53441250083185182118152172183
2013304713500833469101132
Apr;41(2):72-84.319613500834181103117153184199234253265299334355392429442
40.30471450085367490
Sinclair31551450083324886119135168184206
AJ,33791450083416981
Bode347814500833675115151
B,364614500833649
Harris37131450083447799122138165
S,389614500833246
et395914500833457
al.40341450083324862
Efficacy4114145008332516986119153186220
and435214500833270110
Safety44801450083336686121144178
of467614500833858
Canagliflozin475114500834074113146185201217235252291320336375
in514414500831553
Individuals52151450083155393109142159198237270286312
Aged304715500834180116156
75322015500833468
and330515500833271110
Older343315500834764103139161
with36111550083516790129
Type375715500833361102138
23912155008335
Diabetes39641550083456194134170193228255
Mellitus:423715500835490106122138161199226240
A4494155008341
Pooled455215500833573112129164205
Analysis.477415500834180113129161189205231246
J5037155008324
Am507915500834199
Geriatr519615500834380101118150173195
Soc.540815500833372105119
2016304716500833469101133
Mar;64(3):543-52.319716500835488110124160197218252270282318354387410445479492
41.30471750085366982
Aldafas31471750083415797130149183211
R,337517500833650
Crabtree34431750083406295135158180215251
T,371217500833242
Alkharaiji37711750083415888128161183217232248264
M,405317500835468
et413917500833457
al.42141750083314761
Sodium-glucose429317500833271111127165224247288304343375413440476
cotransporter-247871750083316991113147186213252292314340374396416448
inhibitors52531750083145392107147163187224247274
(SGLT2)30471850083195196129159195214
in327918500831453
frail3350185008318417591107
or347518500833759
older35521850083375494129151
people372118500833975115155172207
with39461850083516790129
type40931850083225697133
24244185008334
diabetes42961850083395487127163186221248
and456218500833271111
heart469118500833773105127153
failure:4862185008318526884122144179192
a5072185008332
systematic51221850083265987111145204237259275308
review54481850083215630471950083324883135
and319919500833271110
meta-analysis.332619500835793116150173206244277294326354369396410
Age375319500834180116
Ageing.388519500834180116132170210224
2024412619500833469102135
Jan42771950083255796
2;53(1):afad254.43901950083344783117135168183195229249283322357393429442
42.30472050085367188
Pasqualotto31522050083356895135173206222261284309346
E,351620500833246
Rodrigues357920500833675115137153193231267294
FR,38902050083336883
E3991205008332
Silva4040205008333486497131
Ribeiro41882050083365292128144166204
GB,44092050083448094
et452020500833457
al.45952050083314761
The467320500833373109
effect47992050083345473108142166
of498320500833757
sodium-glucose505720500832765106122160218242283299337370407435471
transporter30472150083224477116143183222245270304326
23394215008334
inhibitors34492150083155492108148164187225247275
on374521500833776
stroke38422150083265072110142176
in403921500831554
patients41132150083397395111147185208236
with43702150083506790129
type45202150083215696133
24673215008335
diabetes:47282150083385487127163186221248261
A5010215008341
meta-analysis.507221500835793116150173206244277294326354369396410
J5503215008324
Stroke30472250083325476114146181
Cerebrovasc32442250083407597131171194231264298325358
Dis.36192250083456188102
2024373822500833469103135
Aug;33(8):107730.389022500834179118131167200219253272285315348381416451486499
43.30472350085367288
Pan315223500833568106
SY,32752350083336978
Su337023500833371
EL,34572350083336579
Huang355323500834483116154194
CJ,37642350083406780
et386123500833457
al.39342350083324862
Evaluation40132350083326598115153186208224263302
of433223500833757
glucose-lowering44062350083385492125163190226249267305357392414430469509
medications493223500835793133149181215237253292331358
in530723500831553
older53772350083375493129151
people:304724500833975114154171206219
a3281245008331
comprehensive332724500833168127167189224263298337364379413447
systematic37892450083265987110145203236259275307
review41102450083215689105140192
and431624500833271110
network44412450083377396149188210241
meta-analysis469624500835893116150173206244277293325353369395
of510624500833757
randomized51772450083215493133171230246276310350
controlled304725500833169108130152190207223258298
trials.3362255008322446093109136150
Age352925500834180115
Ageing.366125500834180116131170210224
2024390125500833469103135
Aug405325500834179118
6;53(8):afae175.41882550083344783117136170189201235254289324355385418431
44.30472650085367591
Kvapil31542650083356599139155171
M,334026500835569
Břízová34242650083365774103141174208
L,364726500833146
Nováková370826500834584116150181219252285
M.400926500835469
Léčba409326500833266100139173
diabetu42812650083385487127163186225
u4521265008337
starších45742650083265083105133148181220
pacientů.480926500833972105121156195217256269
Farmakoter50932650083326384144177207246268303325
Revue543326500833571304727500833271106
2023;8(1):1–5.317027500833469103138150186206238253266296330365377
45.30472850085367186
Kvapil31502850083356598137152167
M,333428500835468
Nováková341828500834583115148178216248281
M.371528500835468
Antidiabetika380028500834179100116155170202241276299314344378
v4194285008332
ordinaci42422850083375997112150182214230
internisty.44882850083155274108129168183209232266276
Acta47802850083417297129
medicinae.492628500835792132147179194232264299311
2022;14:in525428500833468101135148178209221236274
press.30472950083396094121148161
46.30473050085367592
Nováková316130500834585118152183221255289
M,347230500835569
Kvapil356330500833566100141157173
M.375830500835570
Kardiovaskulární38503050083367092132148187220254282313352368402424463479
bezpečnost435230500833975106147183217256296323348
antidiabetik47223050083327194110150166199239276299316347
u5091305008337
seniorů.515130500832662101117156179218231
Svět54053050083326499123
prakt.30473150083396195126151165
medicíny.322831500835894134150182198237268279
2022;4:34-35.352431500833468102138151186199235271294328361374
6.7.7717510014466101160223248
3.1047751001446599
202511757510014465132198265
OLOMOUC8057650014483152241348438525601
20.9826510034812624312086520033348
interní8136820024256170241343420532587
medicína70670000242167270387442527583697801
pro70771700242117193305
praxi105071700242117194295400455
PŘIPRAVOVANÉ38026030016562124156217279343400463522581649701
TEMATICKÉ45256030016553105191253301333385447500
BLOKY:50466030016566116179240299326
38026230011940
Komplikace3884621001284689159205228249291334367409
imunoterapie4310621001282292138184229259300330373418440483
u38846340012846
onkologického3947634001284390131174197241287309343385426473517
pacienta4481634001284588121144186233263306
38026510011940
Racionální3884650001284790123146190236279301348370
ATB4271650001284883131
terapie4419650001283072101144189212254
38026660011940
Alergologie3884665001284870112142188232255299344367409
38026820011940
Case3884680001284184117160
Based4061680001284891124167213
Learning4290680001283981124153200222269315
38026970011940
Blok3884696001284871115156
ambulantních40576960012843112158204227269316346393415449496
internistů457069600128216899140169217239272303349
38027130011940
Kardiovaskulární3884711001284689118165187231270313346387433456498528575597
onemocnění4498711001284490133203247281328370417439
38027280011940
Perspektivy3884727001284687116151196239280313335376418
medicíny43197270012870112158180214237283322
MÍSTO3810750001025170103136175
KONÁNÍ:4001750001023473116155197216232
CLARION4247750001053570114158183228276
CONGRESS3810760001053578127170215252290327
HOTEL4152760001054691128165201
OLOMOUC4368760001054379123181225272308
Jeremenkova380977000102235476108162194229260292322354
364176770001023366
Průběžně2765749001174269111153192224267305
aktualizovaný3086749001173876106149187208228261301337376419454
program2805759001174169109151179218282
a31027590011738
registrace:3156759001172665107128159188215254285323343
www.kongresinterna.cz27407690011860122185205245287332376406447480502547578618648693735758789825